The Nature of Reflux-respiratory Symptoms Association in Difficult to Treat Wheezing\Coughing Babies

NCT ID: NCT00512382

Last Updated: 2011-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-03-31

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

GER and respiratory symptoms are both common phenomenon in children. Both can coexist in the same patient by chance alone. Research reveals increased incidence for both to coexist leading to suspect a temporal association and possible causality. Therefore we conducted an observational study To determine the primary cause (RS or GER)using for the first time both PH-Impedance as measurements of GER and Wheezy monitoring (WEEM) that records simultaneously wheeze and cough noises. Both modalities will be recorded for 12-24 hours. If GER precedes cough/wheeze recordings it points to GER being the possible precipitating factor and vice versa.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

GER and respiratory symptoms are both common phenomenon in children. Both can coexist in the same patient by chance alone. Research reveals increased incidence for both to coexist leading to suspect a temporal association and possible causality. Therefore we conducted an observational study To determine the primary cause (RS or GER)using for the first time both PH-Impedance as measurements of GER and Wheezy monitoring (WEEM) that records simultaneously wheeze and cough noises. Both modalities will be recorded for 12-24 hours. If GER precedes cough/wheeze recordings it points to GER being the possible precipitating factor.However, If cough/wheeze precedes GER recordings it points to cough/wheeze being the possible precipitating factor. The recordings will be investigated 1 minute before and one minute after each event.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma Cough Wheezing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Babies and small children 1-24 months

WEEM - Wheezy Monitoring

Intervention Type DEVICE

loudspeaker recording (WEEM) is attached externally to the chest simultaneously with PH-Impedance.

B

Children 2-18 years old

WEEM - Wheezy Monitoring

Intervention Type DEVICE

loudspeaker recording (WEEM) is attached externally to the chest simultaneously with PH-Impedance.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

WEEM - Wheezy Monitoring

loudspeaker recording (WEEM) is attached externally to the chest simultaneously with PH-Impedance.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children 1 month - 18 years old
* Difficult to treat asthma
* Difficult to treat cough
* Difficult to treat other respiratory symptoms

Exclusion Criteria

* Children on artificial ventilation
* Children not compliant with PH-Metria and/or WEEM
Minimum Eligible Age

1 Month

Maximum Eligible Age

18 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wolfson Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Avigdor Mandelberg

Director, Pediatric Pulmonry Unit

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Avigdor Mandelberg, MD

Role: STUDY_DIRECTOR

Edith Wolfson Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel aviv

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wolfson Medical center and Sackler School of Medicine, Tel Aviv University, Tel

Holon, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

688 special

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cough Assist in Bronchiolitis
NCT01757496 TERMINATED NA
Eliminating Monitor Overuse Trial (EMO Trial)
NCT05132322 ACTIVE_NOT_RECRUITING NA